Literature DB >> 15236449

Development of solid lipid nanoparticles containing ionically complexed chemotherapeutic drugs and chemosensitizers.

Ho Lun Wong1, Reina Bendayan, Andrew Mike Rauth, Xiao Yu Wu.   

Abstract

The purpose of this study was to develop and characterize a solid lipid nanoparticle (SLN) system containing an anionic polymer for the delivery of cationic antineoplastic agents and chemosensitizers. Ionic complexation was utilized to enhance the loading of these highly water-soluble drugs. The influence of anionic compounds and polymers on drug partition and loading into SLNs was investigated, and dextran sulfate (DS) was found to be the most suitable among those studied. SLNs loaded with doxorubicin and various model chemosensitizers (e.g., verapamil) were thus prepared by incorporating DS using a microemulsion method. The particle size was measured with photon correlation spectroscopy. The mean diameter of the SLNs ranged from 180 to 300 nm, depending on the type and content of the drug and the polymer. The particles possessed weakly negative surface charges as determined by zeta potential measurements. Most polymer-loaded SLNs released half of the drug in the first a few hours and the remaining drug in 15 h or more. The presence of counterions in the medium, especially divalent ions, promoted drug release. Dual drug (doxorubicin/verapamil or quinidine/verapamil)-loaded DS-SLNs were also formulated, which released both drugs without noticeable interference to each other. These studies have laid the foundation for a "one-bullet" dosage form that may provide convenient and effective delivery of multiple drug treatment of tumors. Copyright 2004 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 93:1993-2008, 2004

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15236449     DOI: 10.1002/jps.20100

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  25 in total

Review 1.  Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications.

Authors:  Paul Galvin; Damien Thompson; Katie B Ryan; Anna McCarthy; Anne C Moore; Conor S Burke; Maya Dyson; Brian D Maccraith; Yurii K Gun'ko; Michelle T Byrne; Yuri Volkov; Chris Keely; Enda Keehan; Michael Howe; Conor Duffy; Ronan MacLoughlin
Journal:  Cell Mol Life Sci       Date:  2011-10-21       Impact factor: 9.261

2.  Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line.

Authors:  Niladri Chattopadhyay; Jason Zastre; Ho-Lun Wong; Xiao Yu Wu; Reina Bendayan
Journal:  Pharm Res       Date:  2008-05-31       Impact factor: 4.200

3.  miR-542-3p Appended Sorafenib/All-trans Retinoic Acid (ATRA)-Loaded Lipid Nanoparticles to Enhance the Anticancer Efficacy in Gastric Cancers.

Authors:  Tong Li; Yu Zhang; Yuan-Pu Meng; Li-Shan Bo; Wen-Bo Ke
Journal:  Pharm Res       Date:  2017-11-27       Impact factor: 4.200

4.  A novel polymer-lipid hybrid nanoparticle for efficient nonviral gene delivery.

Authors:  Jian Li; Ying-zi He; Wen Li; Yun-zhen Shen; Yu-ru Li; Yun-feng Wang
Journal:  Acta Pharmacol Sin       Date:  2010-03-29       Impact factor: 6.150

5.  A novel nanoparticle formulation overcomes multiple types of membrane efflux pumps in human breast cancer cells.

Authors:  Preethy Prasad; Ji Cheng; Adam Shuhendler; Andrew M Rauth; Xiao Yu Wu
Journal:  Drug Deliv Transl Res       Date:  2012-04       Impact factor: 4.617

6.  Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer.

Authors:  David Powell; Sruti Chandra; Kyra Dodson; Farhana Shaheen; Kylar Wiltz; Shubha Ireland; Muniruzzaman Syed; Srikanta Dash; Thomas Wiese; Tarun Mandal; Anup Kundu
Journal:  Eur J Pharm Biopharm       Date:  2017-01-25       Impact factor: 5.571

7.  Applications of nanoparticle drug delivery systems for the reversal of multidrug resistance in cancer.

Authors:  Yinghong Huang; Susan P C Cole; Tiange Cai; Y U Cai
Journal:  Oncol Lett       Date:  2016-05-17       Impact factor: 2.967

Review 8.  Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.

Authors:  Phatsapong Yingchoncharoen; Danuta S Kalinowski; Des R Richardson
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

9.  Characterization and evaluation of 5-fluorouracil-loaded solid lipid nanoparticles prepared via a temperature-modulated solidification technique.

Authors:  Meghavi N Patel; Sushant Lakkadwala; Mohamed S Majrad; Elisha R Injeti; Steven M Gollmer; Zahoor A Shah; Sai Hanuman Sagar Boddu; Jerry Nesamony
Journal:  AAPS PharmSciTech       Date:  2014-07-18       Impact factor: 3.246

10.  Amphiphilic poly{[alpha-maleic anhydride-omega-methoxy-poly(ethylene glycol)]-co-(ethyl cyanoacrylate)} graft copolymer nanoparticles as carriers for transdermal drug delivery.

Authors:  Jinfeng Xing; Liandong Deng; Jun Li; Anjie Dong
Journal:  Int J Nanomedicine       Date:  2009-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.